Wait, we have a special offer for you! ✋

Get your exclusive discount now

Use FY25SAVE to get flat 20% off on the report No, I'd pay the full price

Terms & Conditions : This coupon is vaild exclusively for Global Market Reports 2025 and can be used Until March 31 , 2025 .

Global Glomerulonephritis Market Report 2025

Glomerulonephritis Global Market Report 2025 - By Type (Acute Glomerulonephritis, Chronic Glomerulonephritis), By Diagnosis (Urine And Blood Tests, Imaging Tests, Kidney Biopsy, Other Diagnosis), By Treatment (Medication, Surgery, Dialysis, Other Treatments), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels), By End-User (Hospitals, Specialty Clinics, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Glomerulonephritis Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : March 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Glomerulonephritis Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

What Is Covered Under Glomerulonephritis Market

Glomerulonephritis is a kidney disorder characterized by inflammation of the glomeruli, the tiny filters in the kidneys that remove waste and excess fluids from the blood. It can result from infections, autoimmune diseases, or other underlying conditions, leading to symptoms such as blood in urine, proteinuria, and swelling. If left untreated, it may progress to chronic kidney disease or kidney failure.

The main types of glomerulonephritis are acute glomerulonephritis and chronic glomerulonephritis. Acute glomerulonephritis is a sudden kidney inflammation that is often infection-induced and requires prompt treatment to prevent long-term damage. It is diagnosed by various diagnoses such as urine and blood tests, imaging tests, kidney biopsy, and others, and treated with several treatments, including medication, surgery, dialysis, and others. It is distributed through various distribution channels such as hospital pharmacies, retail pharmacies, and others and used by various end-users, including hospitals, specialty clinics, and others.

How Is The Glomerulonephritis Market Segmented?

The glomerulonephritis market covered in this report is segmented –

1) By Type: Acute Glomerulonephritis, Chronic Glomerulonephritis

2) By Diagnosis: Urine And Blood Tests, Imaging Tests, Kidney Biopsy, Other Diagnosis

3) By Treatment: Medication, Surgery, Dialysis, Other Treatments

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels

5) By End-User: Hospitals, Specialty Clinics, Other End-Users

Subsegments:

1) By Acute Glomerulonephritis: Post-infectious Glomerulonephritis, IgA Nephropathy, Lupus Nephritis, Rapidly Progressive Glomerulonephritis (RPGN), Goodpasture Syndrome

2) By Chronic Glomerulonephritis: Focal Segmental Glomerulosclerosis (FSGS), Membranous Nephropathy, Minimal Change Disease, Alport Syndrome, Diabetic Nephropathy, Hypertensive Nephrosclerosis

Glomerulonephritis Market Size and growth rate 2025 to 2029: Graph

What Is The Glomerulonephritis Market Size 2025 And Growth Rate?

The glomerulonephritis market size has grown strongly in recent years. It will grow from $11.06 billion in 2024 to $11.64 billion in 2025 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to the rising prevalence of kidney disorders, the prevalence of infections such as post-streptococcal glomerulonephritis, the rise in research and development, the increase in the incidence of kidney failure, and the growth in awareness regarding kidney diseases.

What Is The Glomerulonephritis Market Growth Forecast?

The glomerulonephritis market size is expected to see strong growth in the next few years. It will grow to $14.14 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to increasing incidences of diabetes, an aging population, increasing investments in healthcare expenditure, an increase in the number of patients on dialysis, and rising cases of autoimmune diseases. Major trends in the forecast period include the launch of new treatments and therapies, advances in diagnostic technologies, novel therapeutics and therapies, collaboration between companies, and intravenous immunoglobulin therapy.

Book your 30 minutes free consultation with our research experts

Contact Us

What Is Driving The Glomerulonephritis Market: Rising Prevalence Of Kidney Disorders Driving The Market Growth

The rising prevalence of kidney disorders is expected to propel the growth of the glomerulonephritis market going forward. Kidney disorders refer to a range of conditions that affect the structure or function of the kidneys, leading to impaired filtration, waste removal, and fluid balance. The rising prevalence of kidney disorders is due to factors such as aging populations, rising rates of chronic diseases such as diabetes and hypertension, and lifestyle choices. Kidney disorders contribute to glomerulonephritis by triggering immune system dysfunction, chronic inflammation, or structural damage, leading to impaired kidney filtration and function. For instance, in December 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, chronic kidney disease (CKD) mortality rates increased by 4.2% in 2021 and 6.2% in 2022. In 2021–22, CKD was noted in around 2 million hospitalizations, representing 18% of all hospitalizations in Australia. Therefore, the rising prevalence of kidney disorders will drive the growth of the glomerulonephritis market.

Who Are The Major Players In The Global Glomerulonephritis Market?

Major companies operating in the glomerulonephritis market are Pfizer Inc., F. Hoffmann-La Roche Ltd., AstraZeneca PLC, Novartis International AG, Eli Lilly and Company, Asahi Kasei Medical Co. Ltd., Boehringer Ingelheim International GmbH, DaVita Inc., Biogen Inc., Merit Medical Systems Inc., Apellis Pharmaceuticals Inc., MorphoSys AG, Travere Therapeutics Inc., Vera Therapeutics Inc., Calliditas Therapeutics AB, Omeros Corporation, Otsuka Pharmaceutical Co. Ltd., Aurinia Pharmaceuticals Inc., Alexion Pharmaceuticals Inc., NovelMed Therapeutics Inc.

What Are The Key Trends Of The Global Glomerulonephritis Market: Breakthrough Non-Immunosuppressive Treatment For IgA Nephropathy

Major companies operating in the glomerulonephritis market are focusing on developing advanced non-immunosuppressive treatments to address unmet medical needs and improve patient outcomes. Non-immunosuppressive treatments are therapies that do not weaken or suppress the immune system, aiming to treat conditions without compromising immune function. For instance, in September 2024, Travere Therapeutics Inc., a US-based biopharmaceutical company, introduced FILSPARI (sparsentan), approved by the Food and Drug Administration (FDA) for treating IgA nephropathy, a kidney disease. The drug is the only non-immunosuppressive treatment shown to significantly slow kidney function decline in these patients. FILSPARI’s approval marks a major breakthrough in the treatment of IgA nephropathy, which is the most common type of primary glomerulonephritis. The therapy offers a new option for patients who previously had limited choices. This approval highlights Travere's commitment to improving patient outcomes in kidney disease.

What Are Latest Mergers And Acquisitions In The Glomerulonephritis Market: Rona Therapeutics And Keymed Biosciences Partner To Develop Sirna Therapeutics For Glomerulonephritis

In May 2023, Rona Therapeutics Inc., a China-based biopharmaceutical company, partnered with Keymed Biosciences Inc. to address the urgent need for new medicines. This partnership aims to develop first-in-class siRNA therapeutics for Glomerulonephritis. Keymed Biosciences Inc. is a China-based biotechnology company that develops treatments for glomerulonephritis.

What Is The Regional Outlook For The Global Glomerulonephritis Market?

North America was the largest region in the glomerulonephritis market in 2024. The regions covered in the glomerulonephritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the glomerulonephritis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Glomerulonephritis  Market?

The glomerulonephritis market consists of revenues earned by entities by providing services such as immunosuppressive therapy, blood pressure control, and kidney transplants. The market value includes the value of related goods sold by the service provider or included within the service offering. The glomerulonephritis market also includes sales of complement-level test kits, urine protein test kits, and medication. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Glomerulonephritis  Industry?

The glomerulonephritis market research report is one of a series of new reports from The Business Research Company that provides glomerulonephritis market statistics, including the glomerulonephritis industry global market size, regional shares, competitors with the glomerulonephritis market share, detailed glomerulonephritis market segments, market trends, and opportunities, and any further data you may need to thrive in the glomerulonephritis industry. This glomerulonephritis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Glomerulonephritis Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $11.64 billion
Revenue Forecast In 2034 $14.14 billion
Growth Rate CAGR of 5.0% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The glomerulonephritis market covered in this report is segmented –
1) By Type: Acute Glomerulonephritis, Chronic Glomerulonephritis
2) By Diagnosis: Urine And Blood Tests, Imaging Tests, Kidney Biopsy, Other Diagnosis
3) By Treatment: Medication, Surgery, Dialysis, Other Treatments
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
5) By End-User: Hospitals, Specialty Clinics, Other End-Users Subsegments:
1) By Acute Glomerulonephritis: Post-infectious Glomerulonephritis, IgA Nephropathy, Lupus Nephritis, Rapidly Progressive Glomerulonephritis (RPGN), Goodpasture Syndrome
2) By Chronic Glomerulonephritis: Focal Segmental Glomerulosclerosis (FSGS), Membranous Nephropathy, Minimal Change Disease, Alport Syndrome, Diabetic Nephropathy, Hypertensive Nephrosclerosis
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., F. Hoffmann-La Roche Ltd., AstraZeneca PLC, Novartis International AG, Eli Lilly and Company, Asahi Kasei Medical Co. Ltd., Boehringer Ingelheim International GmbH, DaVita Inc., Biogen Inc., Merit Medical Systems Inc., Apellis Pharmaceuticals Inc., MorphoSys AG, Travere Therapeutics Inc., Vera Therapeutics Inc., Calliditas Therapeutics AB, Omeros Corporation, Otsuka Pharmaceutical Co. Ltd., Aurinia Pharmaceuticals Inc., Alexion Pharmaceuticals Inc., NovelMed Therapeutics Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Glomerulonephritis Market Characteristics

    3. Glomerulonephritis Market Trends And Strategies

    4. Glomerulonephritis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

    5. Global Glomerulonephritis Growth Analysis And Strategic Analysis Framework

    5.1. Global Glomerulonephritis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Glomerulonephritis Market Growth Rate Analysis

    5.4. Global Glomerulonephritis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Glomerulonephritis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Glomerulonephritis Total Addressable Market (TAM)

    6. Glomerulonephritis Market Segmentation

    6.1. Global Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Acute Glomerulonephritis

    Chronic Glomerulonephritis

    6.2. Global Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Urine And Blood Test

    Imaging Tests

    Kidney Biopsy

    Other Diagnosis

    6.3. Global Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Medication

    Surgery

    Dialysis

    Other Treatments

    6.4. Global Glomerulonephritis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospital Pharmacy

    Retail Pharmacy

    Other Distribution Channels

    6.5. Global Glomerulonephritis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals

    Specialty Clinics

    Other End-Users

    6.6. Global Glomerulonephritis Market, Sub-Segmentation Of Acute Glomerulonephritis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Post-infectious Glomerulonephritis

    IgA Nephropathy

    Lupus Nephritis

    Rapidly Progressive Glomerulonephritis (RPGN)

    Goodpasture Syndrome

    6.7. Global Glomerulonephritis Market, Sub-Segmentation Of Chronic Glomerulonephritis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Focal Segmental Glomerulosclerosis (FSGS)

    Membranous Nephropathy

    Minimal Change Disease

    Alport Syndrome

    Diabetic Nephropathy

    Hypertensive Nephrosclerosis

    7. Glomerulonephritis Market Regional And Country Analysis

    7.1. Global Glomerulonephritis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Glomerulonephritis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Glomerulonephritis Market

    8.1. Asia-Pacific Glomerulonephritis Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Glomerulonephritis Market

    9.1. China Glomerulonephritis Market Overview

    9.2. China Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Glomerulonephritis Market

    10.1. India Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Glomerulonephritis Market

    11.1. Japan Glomerulonephritis Market Overview

    11.2. Japan Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Glomerulonephritis Market

    12.1. Australia Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Glomerulonephritis Market

    13.1. Indonesia Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Glomerulonephritis Market

    14.1. South Korea Glomerulonephritis Market Overview

    14.2. South Korea Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Glomerulonephritis Market

    15.1. Western Europe Glomerulonephritis Market Overview

    15.2. Western Europe Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Glomerulonephritis Market

    16.1. UK Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Glomerulonephritis Market

    17.1. Germany Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Glomerulonephritis Market

    18.1. France Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Glomerulonephritis Market

    19.1. Italy Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Glomerulonephritis Market

    20.1. Spain Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Glomerulonephritis Market

    21.1. Eastern Europe Glomerulonephritis Market Overview

    21.2. Eastern Europe Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Glomerulonephritis Market

    22.1. Russia Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Glomerulonephritis Market

    23.1. North America Glomerulonephritis Market Overview

    23.2. North America Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Glomerulonephritis Market

    24.1. USA Glomerulonephritis Market Overview

    24.2. USA Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Glomerulonephritis Market

    25.1. Canada Glomerulonephritis Market Overview

    25.2. Canada Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Glomerulonephritis Market

    26.1. South America Glomerulonephritis Market Overview

    26.2. South America Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Glomerulonephritis Market

    27.1. Brazil Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Glomerulonephritis Market

    28.1. Middle East Glomerulonephritis Market Overview

    28.2. Middle East Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Glomerulonephritis Market

    29.1. Africa Glomerulonephritis Market Overview

    29.2. Africa Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Glomerulonephritis Market Competitive Landscape And Company Profiles

    30.1. Glomerulonephritis Market Competitive Landscape

    30.2. Glomerulonephritis Market Company Profiles

    30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

    31. Glomerulonephritis Market Other Major And Innovative Companies

    31.1. Asahi Kasei Medical Co. Ltd.

    31.2. Boehringer Ingelheim International GmbH

    31.3. DaVita Inc.

    31.4. Biogen Inc.

    31.5. Merit Medical Systems Inc.

    31.6. Apellis Pharmaceuticals Inc.

    31.7. MorphoSys AG

    31.8. Travere Therapeutics Inc.

    31.9. Vera Therapeutics Inc.

    31.10. Calliditas Therapeutics AB

    31.11. Omeros Corporation

    31.12. Otsuka Pharmaceutical Co. Ltd.

    31.13. Aurinia Pharmaceuticals Inc.

    31.14. Alexion Pharmaceuticals Inc.

    31.15. NovelMed Therapeutics Inc.

    32. Global Glomerulonephritis Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Glomerulonephritis Market

    34. Recent Developments In The Glomerulonephritis Market

    35. Glomerulonephritis Market High Potential Countries, Segments and Strategies

    35.1 Glomerulonephritis Market In 2029 - Countries Offering Most New Opportunities

    35.2 Glomerulonephritis Market In 2029 - Segments Offering Most New Opportunities

    35.3 Glomerulonephritis Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Glomerulonephritis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Glomerulonephritis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Glomerulonephritis Market, Sub-Segmentation Of Acute Glomerulonephritis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Glomerulonephritis Market, Sub-Segmentation Of Chronic Glomerulonephritis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Glomerulonephritis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Glomerulonephritis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Pfizer Inc. Financial Performance
  • Table 79: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 80: AstraZeneca PLC Financial Performance
  • Table 81: Novartis International AG Financial Performance
  • Table 82: Eli Lilly and Company Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Glomerulonephritis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Glomerulonephritis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Glomerulonephritis Market, Sub-Segmentation Of Acute Glomerulonephritis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Glomerulonephritis Market, Sub-Segmentation Of Chronic Glomerulonephritis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Glomerulonephritis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Glomerulonephritis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Glomerulonephritis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Glomerulonephritis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Glomerulonephritis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Pfizer Inc. Financial Performance
  • Figure 79: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 80: AstraZeneca PLC Financial Performance
  • Figure 81: Novartis International AG Financial Performance
  • Figure 82: Eli Lilly and Company Financial Performance

Global Hospital-Acquired Infection Control Market 2022 – Market Opportunities And Strategies

Read More

What Is The Healthcare IT Consulting Market Overview In 2022?

Read More

How Will The Stem Cell Assay Market Grow In 2022?

Read More

Latest Single Use Bioprocessing Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the rcm market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the medical tourism market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the clinical chemistry market market research report 2022 with industry size, share, segments and market growth

Read More

Listeria Monocytogenes Infections Treatment Global Market Report 2024 – By Drug Class (Ampicillin, Gentamicin, Vancomycin, Other Drug Classes), By Type Of Infection ( Gastroenteritis, Endocarditis, Meningitis, Bacteremia, Brain Abscess), By Mode Of Administration (Oral, Injectable, Other Mode Of Administrations), By End Users (Hospitals, Home Care, Specialty Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Invasive Fungal Infections Global Market Report 2025 – By Disease Type (Candidaemi And Invasive Candidiasis, Intra Abdominal Candidiasis, Cryptococcal Meningitis, Esophageal Candidiasis, Histoplasmosis Acute Pulmonary, Other Disease Type), By Drug Type (Polyenes, Triazoles, Echinocandins, Flucytosine, Other Drug Type), By End-Users (Hospitals, Homecare, Specialty Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Acute Bacterial Skin And Skin Structure Infections Global Market Report 2025 – By Type Of Infection (Hospital-acquired Acute Bacterial Skin And Skin Structure Infections, Community-acquired Acute Bacterial Skin And Skin Structure Infections), By Active Ingredients (Delafloxacin, Vancomycin, Ceftaroline fosamil, Oritavancin, Tedizolid, Daptomycin, Tigecycline, Linezolid, Other Active Ingredients), By Route of Administration (Oral, Parenteral, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application (Cellulitis, Abscess, Surgical Wounds, Traumatic Wound) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Autoimmune Disease Diagnosis Global Market Report 2025 – By Product (Consumables And Assay Kits, Instruments), By End User (Clinical Laboratories, Hospitals, Others), By Test Type (Routine Laboratory Tests, Autoantibodies Tests, Immunologic Tests, Other Tests) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Autoimmune Treatment Global Market Report 2025 – By Product (Consumables and Assay Kits, Instruments, Services), By Service Type (Consultation and Diagnosis, Therapy and monitoring, Drug development), By Disease (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome, Thyroiditis, Scleroderma, Other Diseases), By Drug Class (Anti-Inflammatory, Anti-Hyperglycemic, NSAIDs, Interferons, Other Drug Class), By End User (Clinical Laboratories, Hospitals, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Hospital Acquired Infections Testing Kits Global Market Report 2025 – By Product (Consumables And Reagents, Instruments), By Test Type (Pneumonia Infection, Urinary Track Infection, Blood Stream Associated Infection, Surgical Site Infection, MRSA infection, Others), By Pathogen Type (Viral, Bacterial, Fungal), By Application (Drug Resistance Testing, Disease Testing) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Complicated Skin And Skin Structure Infections Drugs Global Market Report 2025 – By Active Ingredients (Delafloxacin, Vancomycin, Ceftaroline Fosamil, Linezolid, Other Active Ingredients), By Route of Administration (Oral, Topical, Parenteral), By End User (Hospitals, Homecare, Specialty Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Sexually Transmitted Infections (STIs) Global Market Report 2025 – By Type (Human Immunodeficiency Virus (HIV), Human Papilloma Virus (HPV), Gonorrhea, Syphilis, Other Types), By Treatment (Antibiotics, Antiviral), By Location Of Testing (Laboratory Testing, Point-Of-Care (POC) Testing), By Route Of Administration (Oral, Parenteral, Other Route Of Administration), By End-Users (Hospitals, Specialty Clinics, Homecare, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Glomerulonephritis market?

Glomerulonephritis is a kidney disorder characterized by inflammation of the glomeruli, the tiny filters in the kidneys that remove waste and excess fluids from the blood. It can result from infections, autoimmune diseases, or other underlying conditions, leading to symptoms such as blood in urine, proteinuria, and swelling. If left untreated, it may progress to chronic kidney disease or kidney failure. For further insights on the Glomerulonephritis market, request a sample here

How will the Glomerulonephritis market drivers and restraints affect the market dynamics? What forces will shape the Glomerulonephritis industry going forward?

The Glomerulonephritis market major growth driver - Rising Prevalence Of Kidney Disorders Driving The Market Growth. For further insights on the Glomerulonephritis market, request a sample here

What is the forecast market size or the forecast market value of the Glomerulonephritis market?

The Glomerulonephritis market size has grown strongly in recent years. The glomerulonephritis market size has grown strongly in recent years. It will grow from $11.06 billion in 2024 to $11.64 billion in 2025 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to the rising prevalence of kidney disorders, the prevalence of infections such as post-streptococcal glomerulonephritis, the rise in research and development, the increase in the incidence of kidney failure, and the growth in awareness regarding kidney diseases. The glomerulonephritis market size is expected to see strong growth in the next few years. It will grow to $14.14 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to increasing incidences of diabetes, an aging population, increasing investments in healthcare expenditure, an increase in the number of patients on dialysis, and rising cases of autoimmune diseases. Major trends in the forecast period include the launch of new treatments and therapies, advances in diagnostic technologies, novel therapeutics and therapies, collaboration between companies, and intravenous immunoglobulin therapy. For further insights on the Glomerulonephritis market, request a sample here

How is the Glomerulonephritis market segmented?

The glomerulonephritis market covered in this report is segmented –
1) By Type: Acute Glomerulonephritis, Chronic Glomerulonephritis
2) By Diagnosis: Urine And Blood Tests, Imaging Tests, Kidney Biopsy, Other Diagnosis
3) By Treatment: Medication, Surgery, Dialysis, Other Treatments
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
5) By End-User: Hospitals, Specialty Clinics, Other End-Users

Subsegments:
1) By Acute Glomerulonephritis: Post-infectious Glomerulonephritis, IgA Nephropathy, Lupus Nephritis, Rapidly Progressive Glomerulonephritis (RPGN), Goodpasture Syndrome
2) By Chronic Glomerulonephritis: Focal Segmental Glomerulosclerosis (FSGS), Membranous Nephropathy, Minimal Change Disease, Alport Syndrome, Diabetic Nephropathy, Hypertensive Nephrosclerosis For further insights on the Glomerulonephritis market, request a sample here

Which region has the largest share of the Glomerulonephritis market? What are the other regions covered in the report?

North America was the largest region in the glomerulonephritis market in 2024. The regions covered in the glomerulonephritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Glomerulonephritis market, request a sample here.

Who are the major players in the Glomerulonephritis market?

Major companies operating in the glomerulonephritis market are Pfizer Inc., F. Hoffmann-La Roche Ltd., AstraZeneca PLC, Novartis International AG, Eli Lilly and Company, Asahi Kasei Medical Co. Ltd., Boehringer Ingelheim International GmbH, DaVita Inc., Biogen Inc., Merit Medical Systems Inc., Apellis Pharmaceuticals Inc., MorphoSys AG, Travere Therapeutics Inc., Vera Therapeutics Inc., Calliditas Therapeutics AB, Omeros Corporation, Otsuka Pharmaceutical Co. Ltd., Aurinia Pharmaceuticals Inc., Alexion Pharmaceuticals Inc., NovelMed Therapeutics Inc. . For further insights on the Glomerulonephritis market, request a sample here.

What are the key trends in the Glomerulonephritis market?

Major trends in the Glomerulonephritis market include Breakthrough Non-Immunosuppressive Treatment For IgA Nephropathy. For further insights on the Glomerulonephritis market, request a sample here.

What are the major opportunities in the Glomerulonephritis market? What are the strategies for the Glomerulonephritis market?

For detailed insights on the major opportunities and strategies in the Glomerulonephritis market, request a sample here.

How does the Glomerulonephritis market relate to the overall economy and other similar markets?

For detailed insights on the key dynamics influencing the Glomerulonephritis market growth and SWOT analysis of the Glomerulonephritis industry, request a sample here.

For detailed insights on Glomerulonephritis's relation to the overall economy and other similar markets,

What are the latest mergers and acquisitions in the Glomerulonephritis industry? request a sample here.

For detailed insights on the mergers and acquisitions in the Glomerulonephritis industry,

What are the key dynamics influencing the Glomerulonephritis market growth? SWOT analysis of the Glomerulonephritis market. request a sample here.